Postdoctoral Research Assistant

The Postdoctoral research Assistant will join the teams led by Dr Rouault-Pierre & Dr Ana Rio-Machin (Nat Com 2015, 2019, 2020; Cell Stem Cell, 2013; Signal Transduct Target Ther, 2023; Leukemia 2013, 2017, 2018, 2020, 2022, 2024; BJH, 2022, 2024; Sci Trans Med 2022, 2023; Haematologica 2012, 2017) to investigate the contribution of germline variants to the development of haematological diseases in order to improve the diagnosis, early detection and management of familial cases, as well as to unravel new oncogenic mechanisms.

We are seeking a highly-motivated researcher with or to be near completion of a PhD in molecular biology, genomics, bioinformatics or a relevant discipline with expertise in data analysis and omics approaches. Experience in haematology and/or cancer would be desirable.

The Barts Cancer Institute (BCI) is a Cancer Research UK Centre of Excellence whose work aims to transform the lives of those with and at risk of cancer through innovative research in the laboratory, in patients and in populations. It is one of six institutes within The Faculty of Medicine and Dentistry (FMD) BCI is internationally renowned in many areas of cancer research and it combines ground-breaking basic research with the expertise of clinicians and clinician scientists from the Centre for Experimental Cancer Medicine and the Barts NHS Trust to achieve improvements in cancer patient care. BCI is also a partner in the CRUK City of London Major Centre (together with UCL, Kings and the Francis Crick Institute) which is a Centre of Excellence in Biotherapeutics. BCI is committed in supporting and developing future cancer researchers through its extensive postgraduate training.

About Queen Mary

At Queen Mary University of London, we believe that a diversity of ideas helps us achieve the previously unthinkable.

Throughout our history, we've fostered social justice and improved lives through academic excellence. And we continue to live and breathe this spirit today, not because it's simply 'the right thing to do' but for what it helps us achieve and the intellectual brilliance it delivers.

We continue to embrace diversity of thought and opinion in everything we do, in the belief that when views collide, disciplines interact, and perspectives intersect, truly original thought takes form., Barts Cancer Institute (BCI) is part of the Faculty of Medicine and Dentistry and one of the top five cancer research centres in the UK. Our overriding objective is to ensure that our research - which aims to identify ways to prevent cancer and develop better diagnostic techniques and treatments - is relevant to and will impact on cancer patients.

We offer competitive salaries, access to a generous pension scheme, 30 days' leave per annum (pro-rata for part-time/fixed-term), a season ticket loan scheme and access to a comprehensive range of personal and professional development opportunities. In addition, we offer a range of work life balance and family friendly, inclusive employment policies, flexible working arrangements, and campus facilities.